Advertisement
Screener

AIM IMMUNOTECH INC. (AIM) Amortization

2.8 / 5 stars · 68/120 Roast Me

AIM IMMUNOTECH INC. Amortization

AIM IMMUNOTECH INC. (AIM) reported Amortization of $302.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.

Financial Statements › Cash Flow › Operating Activities

us-gaap:AdjustmentForAmortization · last filed 2025-03-27

  • AIM IMMUNOTECH INC. amortization for the quarter ending 2024-12-31 was $70.00K.
  • AIM IMMUNOTECH INC. amortization for the quarter ending 2024-09-30 was $95.00K.
  • AIM IMMUNOTECH INC. amortization for the quarter ending 2015-09-30 was $87.00K, a 36.96% decline year-over-year.
  • AIM IMMUNOTECH INC. amortization for the quarter ending 2015-06-30 was $8.00K, a 92.79% decline year-over-year.
  • AIM IMMUNOTECH INC. amortization for fiscal 2024 was $302.00K.
  • AIM IMMUNOTECH INC. amortization for fiscal 2014 was $477.00K, a 143.37% increase from fiscal 2013.
  • AIM IMMUNOTECH INC. amortization for fiscal 2013 was $196.00K, a 390.00% increase from fiscal 2012.
  • AIM IMMUNOTECH INC. amortization for fiscal 2012 was $40.00K, a 75.76% decline from fiscal 2011.
Period endAmortization 3 monthAmortization 6 monthAmortization 9 monthAmortization 12 month
2024-12-31$70.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
$165.00K
derived: sum of 2 quarters · filed 2025-03-27
$302.00K
10-K · filed 2025-03-27
2024-09-30$95.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$232.00K
10-Q · filed 2024-11-14
2024-06-30$137.00K
10-Q · filed 2024-08-14
2015-09-30$87.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16
$95.00K
derived: sum of 2 quarters · filed 2015-11-16
$166.00K
10-Q · filed 2015-11-16
$229.00K
derived: sum of 4 quarters · filed 2015-11-16
2015-06-30$8.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12
$79.00K
10-Q · filed 2015-08-12
$142.00K
derived: sum of 3 quarters · filed 2015-08-12
$280.00K
derived: sum of 4 quarters · filed 2015-11-16
2015-03-31$71.00K
10-Q · filed 2015-05-12
$134.00K
derived: sum of 2 quarters · filed 2015-05-12
$272.00K
derived: sum of 3 quarters · filed 2015-11-16
$383.00K
derived: sum of 4 quarters · filed 2015-11-16
2014-12-31$63.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19
$201.00K
derived: sum of 2 quarters · filed 2015-11-16
$312.00K
derived: sum of 3 quarters · filed 2015-11-16
$477.00K
10-K · filed 2015-03-19
2014-09-30$138.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16
$249.00K
derived: sum of 2 quarters · filed 2015-11-16
$414.00K
10-Q · filed 2015-11-16
$466.00K
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30$111.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12
$276.00K
10-Q · filed 2015-08-12
$328.00K
derived: sum of 3 quarters · filed 2015-08-12
$385.00K
derived: sum of 4 quarters · filed 2015-08-12
2014-03-31$165.00K
10-Q · filed 2015-05-12
$217.00K
derived: sum of 2 quarters · filed 2015-05-12
$274.00K
derived: sum of 3 quarters · filed 2015-05-12
$357.00K
derived: sum of 4 quarters · filed 2015-05-12
2013-12-31$52.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19
$109.00K
derived: sum of 2 quarters · filed 2015-03-19
$192.00K
derived: sum of 3 quarters · filed 2015-03-19
$196.00K
10-K · filed 2015-03-19
2013-09-30$57.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
$140.00K
derived: sum of 2 quarters · filed 2014-11-07
$144.00K
10-Q · filed 2014-11-07
$155.00K
derived: sum of 4 quarters · filed 2015-03-19
2013-06-30$83.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
$87.00K
10-Q · filed 2014-08-08
$98.00K
derived: sum of 3 quarters · filed 2015-03-19
$122.00K
derived: sum of 4 quarters · filed 2015-03-19
2013-03-31$4.00K
10-Q · filed 2014-05-09
$15.00K
derived: sum of 2 quarters · filed 2015-03-19
$39.00K
derived: sum of 3 quarters · filed 2015-03-19
$42.00K
derived: sum of 4 quarters · filed 2015-03-19
2012-12-31$11.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19
$35.00K
derived: sum of 2 quarters · filed 2015-03-19
$38.00K
derived: sum of 3 quarters · filed 2015-03-19
$40.00K
10-K · filed 2015-03-19
2012-09-30$24.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$27.00K
derived: sum of 2 quarters · filed 2013-11-08
$29.00K
10-Q · filed 2013-11-08
$33.00K
derived: sum of 4 quarters · filed 2014-03-14
2012-06-30$3.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$5.00K
10-Q · filed 2013-08-09
$9.00K
derived: sum of 3 quarters · filed 2014-03-14
$60.00K
derived: sum of 4 quarters · filed 2014-03-14
2012-03-31$2.00K
10-Q · filed 2013-05-08
$6.00K
derived: sum of 2 quarters · filed 2014-03-14
$57.00K
derived: sum of 3 quarters · filed 2014-03-14
$61.00K
derived: sum of 4 quarters · filed 2014-03-14
2011-12-31$4.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14
$55.00K
derived: sum of 2 quarters · filed 2014-03-14
$59.00K
derived: sum of 3 quarters · filed 2014-03-14
$165.00K
10-K · filed 2014-03-14
2011-09-30$51.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02
$55.00K
derived: sum of 2 quarters · filed 2012-11-02
$161.00K
10-Q · filed 2012-11-02
$477.00K
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$4.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08
$110.00K
10-Q · filed 2012-08-08
$426.00K
derived: sum of 3 quarters · filed 2013-03-18
$444.00K
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$106.00K
10-Q · filed 2012-05-07
$422.00K
derived: sum of 2 quarters · filed 2013-03-18
$440.00K
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31$316.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$334.00K
derived: sum of 2 quarters · filed 2013-03-18
$373.00K
10-K · filed 2013-03-18
2010-09-30$18.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09
$57.00K
10-Q · filed 2011-11-09
2010-06-30$39.00K
10-Q · filed 2011-08-05
2009-12-31$381.00K
10-K · filed 2012-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B